Ambrx_ACE-Breast-03

A Global, Phase 2 Study of ARX788 in HER2-Positive Metastatic Breast Cancer Patients who were previously treated with T-DXd

Study Link: https://clinicaltrials.gov/ct2/show/NCT04829604

Eucure YH003004

A phase II, multi-center, open-label study to evaluate the safety and efficacy of YH003 in combination with Toripalimab (anti-PD-1 mAb) in patients with unresectable / metastatic melanoma and pancreatic ductal adenocarcinoma (PDAC)

Study Link: https://clinicaltrials.gov/ct2/show/NCT05031494

Eucure YH003005

A Multicenter, Open-Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors

Study Link: https://clinicaltrials.gov/ct2/show/NCT05176509